Oral administration of doxycycline allows tight control of transgene expression: a key step towards gene therapy of retinal diseases

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Gene Therapy

• Publication date

  2007-10-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.gt.3303034PMID 17914405
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevention of diabetic retinopathy by intraocular soluble flt-1 gene transfer in a spontaneously diabetic rat model.

  2007cited by this paper
• Gene therapy for ocular neovascularization.

  2007cited by this paper
• Ranibizumab for neovascular age-related macular degeneration.

  2007cited by this paper
• ANCHOR STUDY GROUP. RANIBIZUMAB VERSUS VERTEPORFIN FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

  2006cited by this paper
• Regulation of Rod Phototransduction Machinery by Ciliary Neurotrophic Factor

  2006cited by this paper
• Ranibizumab for neovascular age-related macular degeneration.

  2006cited by this paper
• Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants.

  2006cited by this paper
• Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration.

  2006cited by this paper
• Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials.

  2006cited by this paper
• Retinitis pigmentosa.

  2006cited by this paper
• In contrast to AAV-mediated Cntf expression, AAV-mediated Gdnf expression enhances gene replacement therapy in rodent models of retinal degeneration.

  2006cited by this paper
• Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

  2006cited by this paper
• Adeno-Associated Virus-Mediated Expression of Vascular Endothelial Growth Factor Peptides Inhibits Retinal Neovascularization in a Mouse Model of Oxygen-Induced Retinopathy

  2005cited by this paper
• Angiogenesis as a therapeutic target

  2005cited by this paper
• A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema.

  2005cited by this paper
• Angiogenic pathways in diabetic retinopathy.

  2005cited by this paper
• Long-term doxycycline-regulated transgene expression in the retina of nonhuman primates following subretinal injection of recombinant AAV vectors.

  2005cited by this paper
• Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer.

  2005cited by this paper
• VEGF: a critical player in neurodegeneration.

  2004cited by this paper
• RISKS OF INTRAVITREOUS INJECTION: A COMPREHENSIVE REVIEW

  2004cited by this paper
• Optimal design of a single recombinant adeno-associated virus derived from serotypes 1 and 2 to achieve more tightly regulated transgene expression from nonhuman primate muscle.

  2004cited by this paper
• Intraocular gene delivery of ciliary neurotrophic factor results in significant loss of retinal function in normal mice and in the Prph2Rd2/Rd2 model of retinal degeneration

  2003cited by this paper
• Recombinant adeno-associated virus serotype 4 mediates unique and exclusive long-term transduction of retinal pigmented epithelium in rat, dog, and nonhuman primate after subretinal delivery.

  2003cited by this paper
• AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization.

  2002cited by this paper
• Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa.

  2002cited by this paper
• Effects of adeno-associated virus-vectored ciliary neurotrophic factor on retinal structure and function in mice with a P216L rds/peripherin mutation.

  2002cited by this paper
• Adeno-associated virus type-2 expression of pigmented epithelium-derived factor or Kringles 1–3 of angiostatin reduce retinal neovascularization

  2002cited by this paper
• Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy

  2002cited by this paper
• Inhibition of retinal neovascularization by intraocular viral-mediated delivery of anti-angiogenic agents.

  2002cited by this paper
• Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1

  2002cited by this paper
• Lack of an Immune Response against the Tetracycline-Dependent Transactivator Correlates with Long-Term Doxycycline-Regulated Transgene Expression in Nonhuman Primates after Intramuscular Injection of Recombinant Adeno-Associated Virus

  2002cited by this paper
• Recombinant AAV-mediated delivery of a tet-inducible reporter gene to the rat retina.

  2001cited by this paper
• Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa.

  2001cited by this paper
• AAV-mediated delivery of ciliary neurotrophic factor prolongs photoreceptor survival in the rhodopsin knockout mouse.

  2001cited by this paper
• New uses of older antibiotics.

  2001cited by this paper
• Retinal and choroidal neovascularization

  2000cited by this paper
• Factors Influencing Recombinant Adeno-Associated Virus Production

  1998cited by this paper
• Serum concentrations of penicillin, doxycycline, and ciprofloxacin during prolonged therapy in rhesus monkeys.

  1992cited by this paper

• AAV-mediated inducible co-expression of IL-10 and IL-1RN for ocular inflammatory diseases

  2025cites this paper
• Minocycline and Diacetyl Minocycline Eye Drops Reduce Ocular Neovascularization in Mice

  2023cites this paper
• Investigational Agents in Development for the Treatment of Geographic Atrophy Secondary to Age-Related Macular Degeneration

  2021cites this paper
• Generation of an X chromosome reactivation mouse model for Rett syndrome

  2021cites this paper
• Primary open-angle glaucoma: on the development of novel therapeutic approaches

  2018cites this paper
• Complement pathway biomarkers and age-related macular degeneration

  2016cites this paper
• A controlled double-duration inducible gene expression system for cartilage tissue engineering

  2016cites this paper
• A regulatable AAV vector mediating GDNF biological effects at clinically-approved sub-antimicrobial doxycycline doses

  2016cites this paper
• Regulable Transgene Expression in Dorsal Root Ganglia of a Replication-Defective Herpes Simplex Virus Type 1 Vector by Means of Sciatic Nerve Injection

  2016cites this paper
• Gene Transfer for Clinical Congestive Heart Failure

  2015cites this paper
• A Conditionally Replicating Human Immunodeficiency Virus in BRG-HIS Mice

  2014cites this paper
• Gene- and Cell-Based Therapy for Cardiovascular Disease

  2014cites this paper
• Transgene Regulation Using the Tetracycline-Inducible TetR-KRAB System after AAV-Mediated Gene Transfer in Rodents and Nonhuman Primates

  2014cites this paper
• A tetracycline expression system in combination with Sox9 for cartilage tissue engineering.

  2014cites this paper
• Subretinal delivery of AAV2-mediated human erythropoietin gene is protective and safe in experimental diabetic retinopathy.

  2014cites this paper
• Gene transfer for congestive heart failure: update 2013.

  2013cites this paper
• Regulated expression systems for gene therapy

  2013cites this paper
• A mifepristone-regulated adeno-associated viral vector system for regulated neurotrophic factor expression in the central nervous system.

  2013cites this paper
• Update on current and future novel therapies for dry age-related macular degeneration

  2013cites this paper
• Oral Doxycycline Reduces Pterygium Lesions; Results from a Double Blind, Randomized, Placebo Controlled Clinical Trial

  2012cites this paper
• HERAPEUTIC S TRATEGIES FOR H UMAN U SHER S YNDROME

  2011cites this paper
• Neonatal systemic delivery of scAAV9 in rodents and large animals results in gene transfer to RPE cells in the retina.

  2011cites this paper
• Prevention of diabetic neuropathy by regulatable expression of HSV-mediated erythropoietin.

  2011cites this paper
• Prolonged regulatable expression of EPO from an HSV vector using the LAP2 promoter element

  2011cites this paper
• CURRENT THERAPEUTIC STRATEGIES FOR HUMAN USHER SYNDROME

  2011cites this paper
• Evaluation of AAV-mediated expression of Chop2-GFP in the marmoset retina.

  2010cites this paper
• Gene therapy for ocular diseases

  2010cites this paper
• Republished review: Gene therapy for ocular diseases

  2010cites this paper
• Autoregulatory lentiviral vectors allow multiple cycles of doxycycline-inducible gene expression in human hematopoietic cells in vivo

  2010cites this paper
• Regulation of retinal function but nonrescue of vision in RPE65-deficient dogs treated with doxycycline-regulatable AAV vectors.

  2010cites this paper
• Lack of Humoral Immune Response to the Tetracycline (Tet) Activator in Rats Injected Intracranially with Tet-off rAAV Vectors

  2010cites this paper
• AAV-mediated gene therapy for retinal disorders in large animal models.

  2009cites this paper
• Ultrastructural Telepathology: Remote EM Diagnostic via Internet

  2009cites this paper
• In vivo gene regulation using tetracycline-regulatable systems

  2009influential citation
• Differential requirements for retinal degeneration slow intermolecular disulfide-linked oligomerization in rods versus cones.

  2009cites this paper
• Progress toward effective treatments for human photoreceptor degenerations.

  2009cites this paper
• Treatment of lysosomal storage disorders: focus on the neuronal ceroid-lipofuscinoses.

  2008cites this paper
• [The treatment of inherited dystrophies and neovascular disorders of the retina by rAAV-mediated gene therapy].

  2008cites this paper
• Die Behandlung heredit(cid:1)rer Dystrophien und neovaskul(cid:1)rer Erkrankungen der Retina durch AAV-vermittelten Gentransfer The Treatment of Inherited Dystrophies and Neovascular Disorders of the Retina by rAAV-Mediated Gene Therapy

  2008cites this paper